Boston Scientific Grapples With Global IT Shutdown After Cyberattack

The disruption impacts the backbone of the company’s logistics, though leadership has remained tight-lipped regarding the safety of its medical devices. When pressed on whether the incident compromises the pacemakers and defibrillators currently in use by its 48 million annual patients, spokesperson Chanel Hastings declined to comment or provide guidance for those relying on their technology.

Internal network failures have effectively halted shipping and order fulfillment, creating a logistical bottleneck. While the company investigates the scope of the intrusion, thousands of staff members in Cork, Ireland, were forced to vacate their offices as communications systems went dark. The attack marks a growing trend of targeting healthtech infrastructure, following similar breaches at industry peers such as Abbott Laboratories, Medtronic, and Stryker. Boston Scientific has yet to provide a timeline for system restoration or disclose the specific nature of the unauthorized access.